Activatable fluorescent probes for atherosclerosis theranostics

• Published in: iScience Vol. 27; no. 10; p. 111009
• Main Authors: You, Yuanyuan, Tang, Chengwei, Lin, Songling, Li, Wenman, Li, Yuchao, Yan, Dingyuan, Wang, Dong, Chen, Xiaohui
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 18.10.2024
• Subjects: Biomaterials; Cardiovascular medicine; Medical imaging; Optical imaging; Optical materials; Optical imaging; Optical materials; Medical imaging; Cardiovascular medicine; Biomaterials
• ISSN: 2589-0042; 2589-0042
• DOI: 10.1016/j.isci.2024.111009

The onset of atherosclerosis (AS) is insidious, and early stage patients have atypical clinical symptoms. After being diagnosed in late stage, it is often prone to sudden and fatal cardiovascular events. Therefore, it is highly desirable to develop precise and efficient diagnosis and therapy strategies of AS. Benefiting from high signal-to-noise ratio, low detection limit, high specificity and sensitivity, a series of activatable fluorescent probes based on atherosclerotic microenvironment have emerged for identification and treatment of AS. In this review, we focus on the atherosclerotic microenvironment and briefly summarize the correlation between the structural transformation and fluorescence signal changes of mono-/double-activatable fluorescent probes upon biomarkers stimulation. Moreover, their cutting-edge progress for AS theranostics is described. Finally, the outlook for activatable theranostic probes based on atherosclerotic microenvironment is discussed to aim at promoting innovative research in imaging-guided precise AS therapy. [Display omitted] Cardiovascular medicine; Medical imaging; Optical imaging; Biomaterials; Optical materials